Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized study of sarilumab monotherapy in rheumatoid arthritis
2013-002790-22Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sarilumab in rheumatoid arthritis (RA) (2 arms), sponsored by Sanofi. Primary endpoint: Incidence of anti-drug antibodies. Started Apr 2014; status: completed.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2013-002790-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002790-22.